Ozempic, Mounjaro, Wegovy : des cas d’alopécie et de pensées suicidaires analysés https://t.co/7WRebHvK92 — Radio-Canada Info (@RadioCanadaInfo) January 4, 2024 美国中文网综合报道 食品和药物管理局(FDA)正在评估服用Ozempic、Mounjaro和Wegovy等减肥药物的人出现脱发和自杀念头等副作用的报...
Tirzepatide (ZEPBOUND) Approved for Chronic Weight Management in Adults with Obesity The FDA has approved Zepbound (tirzepatide) for chronic weight management in adults with obesity (BMI of 30 kg/ m2 or greater or overweight (BMI of 27 kg/m2 or greater) with at least one… pic.twitter.com/R...
